findmyKOL
Clinical trialNCT04608448CompletedEarly phase 1Interventional

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

SponsorThe University of Texas Health Science Center at San AntonioEnrollment22AgingEpigeneticsInflammatory Mediators
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Topical Rapamycin ointment will be applied to participant forearms to test whether epigenetic changes in the skin are elicited.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uthscsa

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Rapamycin Topical Ointment
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Apr 2021
Primary completion
15 Apr 2022
Completion
15 Apr 2022
Last update posted
19 Jul 2023
Registered enrollment
22
Registry id
NCT04608448
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.